You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Long-Acting Injectable

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-acting Antipsychotics for Mental Ill-Health in Pregnancy

Not yet recruiting
  • Schizophrenia
  • +7 more
    • Makurdi, Benue State, Nigeria
    • +5 more
    Mar 9, 2023

    HIV-positive People, Treated With Long Acting Antiretroviral

    Active, not recruiting
    • HIV Infections
    • Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
    • Milan, Italy
      Ospedale San Raffaele Scientific Institute
    Dec 15, 2022

    HIV Trial (CAB LA)

    Not yet recruiting
    • HIV Infections
    • CAB LA
    • (no location specified)
    Nov 21, 2023

    Schizophrenia, Bipolar I Disorder Trial in United States (Aripiprazole)

    Completed
    • Schizophrenia
    • Bipolar I Disorder
    • Little Rock, Arkansas
    • +3 more
    Aug 31, 2020

    Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

    Completed
    • Opioid-use Disorder
    • Extended release naltrexone
    • Loerenskog, Akershus, Norway
      Akershus University Hospital
    Nov 30, 2022

    HIV Trial in Menlo Park

    Recruiting
    • HIV
      • Menlo Park, California
        Mazonson & Santas Inc
      Jan 13, 2022

      Schizophrenia Trial in Los Angeles (Oral Risperidone, Risperidone in Long-Acting Injectable Form (Consta))

      Completed
      Has Results
      • Schizophrenia
      • Oral Risperidone
      • Risperidone in Long-Acting Injectable Form (Consta)
      • Los Angeles, California
        Semel Institute for Neuroscience and Human Behavior at UCLA
      Mar 8, 2020

      Cisgender Female Patients Who Start on Long Acting Cabotegravir

      Not yet recruiting
      • Hiv
      • Cabotegravir Injection [Apretude]
      • Orlando, Florida
      • +2 more
      Nov 17, 2023

      Opioid Use Disorder Trial (naltrexone implant)

      Not yet recruiting
      • Opioid Use Disorder
      • naltrexone implant
      • (no location specified)
      Dec 7, 2022

      Moderate Asthma Trial (Long-Acting Beta Agonist)

      Not yet recruiting
      • Moderate Asthma
      • Long-Acting Beta Agonist
      • (no location specified)
      Feb 24, 2023

      Long Acting Injectable Medications in Schizophrenia

      Active, not recruiting
      • Schizophrenia
        • Tucson, Arizona
        • +56 more
        Feb 10, 2022

        Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)

        Not yet recruiting
        • Schizophrenia
        • Schizoaffective Disorder
        • (no location specified)
        Mar 24, 2023

        Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

        Not yet recruiting
        • Copd
        • SABA SAMA ICS Vs LABA LAMA ICs
        • Assiut, Egypt
          Nermen Mohammed Abuelkassem
        Feb 28, 2023

        HIV-1-infection, Medication Adherence, Satisfaction, Patient Trial in Little Rock (Home visit delivery strategy)

        Recruiting
        • HIV-1-infection
        • +2 more
        • Home visit delivery strategy
        • Little Rock, Arkansas
          University of Arkansas for Medical Sciences
        Oct 20, 2022

        Growth Disorders Trial (somavaratan, Daily rhGH)

        Completed
        Has Results
        • Growth Disorders
        • (no location specified)
        Nov 28, 2022

        Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

        Active, not recruiting
        • Pulmonary Disease, Chronic Obstructive
        • Tiotropium (Tio)
        • +4 more
        • Taipei, China
          National Tawain University Hospital
        Jan 9, 2023

        Schizophrenia Trial in Catonsville (Paliperidone)

        Withdrawn
        • Schizophrenia
        • Catonsville, Maryland
          Maryland Psychiatric Research Center
        Mar 1, 2022

        Quality of Life, Clinical Response and Safety of Daily and

        Recruiting
        • Growth Hormone Deficiency
        • Growth Hormone Treatment
        • Long-Acting Growth Hormone (LAGH)
        • Minneapolis, Minnesota
          University of Minnesota
        Sep 29, 2022

        HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

        Not yet recruiting
        • HIV-1-infection
        • +2 more
        • CAB + RPV
        • (no location specified)
        Nov 16, 2022

        Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

        Completed
        • Pulmonary Disease, Chronic Obstructive
        • Brussels, Belgium
          Erasme University Hospital
        Jun 23, 2023

        Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

        Not yet recruiting
        • HIV Prevention
        • No intervention
        • Austin, Texas
          Dell Medical School, UT-Austin
        Dec 30, 2022

        Optimizing CAB-LA as PrEP for Women Who Inject Drugs

        Recruiting
        • HIV Infections
        • +2 more
          • Philadelphia, Pennsylvania
            Prevention Point Philadelphia
          Apr 4, 2023

          Oregon PrEP at Home Study

          Not yet recruiting
          • HIV/AIDS
          • Cabotegravir Injection
          • Portland, Oregon
            Oregon Health & Science University
          Jul 15, 2023

          Tibial Meniscus Injuries, Tibial Meniscus Tears, Tibial Meniscus, Torn Trial in Lexington (Zilretta, Placebo)

          Terminated
          • Tibial Meniscus Injuries
          • +3 more
          • Lexington, Kentucky
            UK Healthcare at Turfland
          Jul 21, 2022

          Effectiveness and Cost-effectiveness of LADB

          Not yet recruiting
          • Opioid Dependence
          • long-acting depot buprenorphine (LADB)
          • (no location specified)
          Nov 16, 2023